Firm Analyst
Bank of America
Jason Zemansky
BTIG
Julian Harrison
Cantor Fitzgerald
Prakhar Agrawal
Cowen
Tyler Van Buren
Goldman Sachs
Corinne Jenkins
Guggenheim Securities
Vamil Divan, M.D.
HC Wainwright & Co.
Andrew S. Fein
Jefferies
Kelly Shi, PhD
Oppenheimer
Andreas Argyrides
Piper Sandler
Joseph Catanzaro, Ph.D.
Scotiabank
Greg Harrison, CFA
SVB Leerink
Thomas J. Smith
Truist Securities
Kripa Devarakonda, Ph.D.
Wedbush
Yun Zhong
Wells Fargo
Tiago Fauth
William Blair
Matt Phipps, Ph.D.

Keros Therapeutics is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Keros Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Keros Therapeutics or its management. Keros Therapeutics does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Investor Contact